Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04938167 · ClinicalTrials.gov registry record · NA

Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension

A NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure, sponsored by University of California, Davis.

Active
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT04938167 is a NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 54 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04938167, a NA study of Persistent Pulmonary Hypertension of the Newborn and Hypoxemic Respiratory Failure, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to evaluate two oxygen saturation goals for newborns with pulmonary hypertension. Participation in this research will involve random assignment to one of two oxygen saturation goals, review of the medical record and targeted echocardiograms.

Interventions

  • OTHER 95% - 99% SpO2 target

Study Locations (1)

California

  • University of California-Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2021-08-01
Est. Completion 2025-12-31
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04938167

The ClinicalTrials.gov registry entry for NCT04938167 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Persistent Pulmonary Hypertension of the Newborn appearing as the primary indexed condition, and to 1 intervention - of which 95% - 99% SpO2 target is the first listed.

NCT04938167 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04938167 about?

NCT04938167 is a clinical study titled "Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension". The purpose of this research is to evaluate two oxygen saturation goals for newborns with pulmonary hypertension. Participation in this research will involve random assignment to one of two oxygen saturation goals, review of the medical record and targeted echocardiograms.

What is the current status of trial NCT04938167?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2021-08-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04938167 study?

This clinical trial studies the following conditions: Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure.

What interventions are being tested in trial NCT04938167?

The interventions under investigation include: 95% - 99% SpO2 target (OTHER).

Who is sponsoring clinical trial NCT04938167?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04938167 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Persistent Pulmonary Hypertension of the Newborn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.